We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
-4.82%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$77.9M
AUM Growth
+$11.2M
Cap. Flow
+$16.2M
Cap. Flow %
20.77%
Top 10 Hldgs %
91.07%
Holding
36
New
8
Increased
13
Reduced
5
Closed
6

Top Buys

1
CVS icon
CVS Health
CVS
+$3.12M
2
ABT icon
Abbott
ABT
+$2.97M
3
EHAB
Enhabit
EHAB
+$787K
4
ODP
ODP
ODP
+$481K
5
SEAT icon
Vivid Seats
SEAT
+$295K

Top Sells

1
ZVRA icon
Zevra Therapeutics
ZVRA
+$250K
2
NFLX icon
Netflix
NFLX
+$229K
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$163K
4
COMS
COMSovereign Holding Corp. Common Stock
COMS
+$38.5K
5
ADBE icon
Adobe
ADBE
+$11K

Sector Composition

1 Healthcare 52.5%
2 Industrials 16.5%
3 Communication Services 9.34%
4 Financials 4.95%
5 Technology 1.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
1
CVS Health
CVS
$137B
$13.8M 17.68%
197,212
+43,975
+29% +$3.12M
RCM
2
DELISTED
R1 RCM Inc. Common Stock
RCM
$12.7M 16.27%
841,000
– –
BMRN icon
3
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.85M 11.36%
100,000
– –
ZBH icon
4
Zimmer Biomet
ZBH
$17.6B
$7.27M 9.33%
64,742
+2,208
+4% +$280K
ABT icon
5
Abbott
ABT
$175B
$6.75M 8.66%
69,690
+28,275
+68% +$2.97M
GOOG icon
6
CALL
Alphabet (Google) Class C
GOOG
$4.22T
$6.07M 7.79%
+46,000
New +$5.98M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.22T
$6.07M 7.79%
46,000
– –
ABT icon
8
CALL
Abbott
ABT
$175B
$3.49M 4.48%
+36,000
New +$3.78M
EHTH icon
9
eHealth
EHTH
$47.3M
$3.03M 3.9%
410,000
+30,000
+8% +$236K
TEVA icon
10
Teva Pharmaceuticals
TEVA
$37.3B
$2.98M 3.83%
292,500
-17,500
-6% -$163K
EHAB
11
DELISTED
Enhabit
EHAB
$816K 1.05%
72,500
+62,500
+625% +$787K
UNG icon
12
CALL
United States Natural Gas Fund
UNG
$374M
$683K 0.88%
+25,000
New +$699K
EHAB
13
CALL
DELISTED
Enhabit
EHAB
$596K 0.77%
+53,000
New +$667K
ODP
14
DELISTED
ODP
ODP
$462K 0.59%
+10,000
New +$481K
VYNE icon
15
VYNE Therapeutics
VYNE
$25.4M
$460K 0.59%
115,000
– –
MSFT icon
16
Microsoft
MSFT
$2.93T
$372K 0.48%
1,179
+106
+10% +$35K
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$4.23T
$371K 0.48%
2,838
-27
-0.9% -$3.49K
META icon
18
Meta Platforms (Facebook)
META
$1.64T
$360K 0.46%
1,200
+8
+0.7% +$2.41K
SEAT icon
19
Vivid Seats
SEAT
$77.9M
$321K 0.41%
2,500
+2,000
+400% +$295K
V icon
20
Visa
V
$682B
$295K 0.38%
1,282
-8
-0.6% -$1.92K
MA icon
21
Mastercard
MA
$480B
$293K 0.38%
741
-18
-2% -$7.22K
ADBE icon
22
Adobe
ADBE
$94.3B
$262K 0.34%
513
-21
-4% -$11K
ACN icon
23
Accenture
ACN
$87.9B
$253K 0.32%
823
+10
+1% +$3.15K
CRM icon
24
Salesforce
CRM
$140B
$252K 0.32%
1,243
+59
+5% +$12.7K
BRK.B icon
25
Berkshire Hathaway Class B
BRK.B
$1.06T
$234K 0.3%
667
+39
+6% +$13.8K
1
2

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, DSC Advisors held 36 positions worth $77.9M, up 17% from $66.7M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

DSC Advisors deployed $16.2M of net new capital in Q3 2023, opening 8 new positions and adding to 13 existing holdings. Its largest new stake was ODP: 10,000 shares worth $462K.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 54% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $163K trimmed.

  • DSC Advisors's largest Q3 2023 buy was ODP: 10,000 shares worth $462K.
  • DSC Advisors added most to CVS Health in Q3 2023, an estimated $3.12M increase.
  • DSC Advisors's biggest Q3 2023 reduction was Teva Pharmaceuticals, cutting an estimated $163K.
  • DSC Advisors fully exited Zevra Therapeutics in Q3 2023, selling an estimated $250K.
  • DSC Advisors's ten largest holdings make up 91% of its $77.9M portfolio in Q3 2023.
  • DSC Advisors opened 8 new positions and closed 6 in Q3 2023.
  • DSC Advisors's portfolio value rose 17% quarter-over-quarter to $77.9M.

Based on DSC Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.